Abstract
Colorectal cancer (CRC) is a common malignancy worldwide. In CRC patients, metastases are the main cause of cancer-related mortality. In a group of metastatic CRC patients, the metastases are limited to a single site (solitary organ); the liver and lungs are the most commonly involved sites. When metastatic disease is limited to the liver and/or lungs, the resectability of the metastatic lesions will dictate the management approach and the outcome. Less commonly, the site of solitary organ CRC metastasis is the peritoneum. In these patients, cytoreduction followed by hyperthermic intraperitoneal chemotherapy may improve the outcome. Rarely, CRC involves other organs, such as the brain, bone, adrenals and spleen, as the only site of metastatic disease. There are limited data to guide clinical practice in these cases. Here, we have reviewed the disease characteristics, management approaches and prognosis based on the metastatic disease site in patients with CRC with metastases to a single organ.
Original language | English |
---|---|
Pages (from-to) | 11767-11776 |
Number of pages | 10 |
Journal | World Journal of Gastroenterology |
Volume | 21 |
Issue number | 41 |
DOIs | |
Publication status | Published - 7 Nov 2015 |
Keywords
- Bone metastasis
- Brain metastasis
- Colorectal cancer
- Disease management
- Liver metastasis
- Lung metastasis
- Metastasis; Prognosis
- Peritoneal metastasis